Home/ Supplements/ Niacin/ Testosterole Maximum Libido Complex

Testosterole Maximum Libido Complex

product on market Capsule Maximum International Safety: 77/100
77/100

Review before taking

  • Niacin: 45mg is 1.3× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Niacin and zinc are supported by moderate evidence for supporting metabolic function and hormonal health. However, the inclusion of a proprietary blend limits the ability to assess specific dosage efficacy. Overall, the evidence coverage for this specific formulation is very low.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 45mg is 1.3× the Tolerable Upper Intake Level (35mg)

Contains proprietary blend — exact ingredient amounts not disclosed

AI-generated · Qwen 3.6 · grounded in 2 sources · methodology

This product has a lower safety score because it contains more Niacin than the recommended daily upper limit and uses a proprietary blend that hides the exact amount of each ingredient.

Label

Product Label

Label for Testosterole Maximum Libido Complex
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

45 mg (225% DV)
Exceeds UL by 1.3× (UL: 35 mg) 196 studies (A:5, B:63)
10 mg (67% DV)
Within RDA (0.9× RDA) 263 studies (A:6, B:134)
Proprietary Blend
847 mg

Other Ingredients

Cellulose Magnesium Stearate Silicon Dioxide
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Recommended Use: Take two (2) capsules daily, as a dietary supplement.

Warnings & Precautions

Not intended for women.

WARNING: Not intended for use by those with a medical condition. Use only as directed. Do not exceed the recommended daily intake.

DO NOT use if safety seal is broken or missing.

CAUTION: Not for use by persons under the age of 18.

This product is not to be taken by pregnant or lactating women. If you are taking medication or have a medical condition, consult a physician before using this product.

KEEP OUT OF REACH OF CHILDREN!

Additional Information

Made in the USA

REV 02-10

Store in a cool and dry place

Metadata

Product Details

DSLD Entry Date2015-05-22
Product TypeOther Combinations
FormCapsule
DSLD ID45158
Data Updated2026-04-11
Research

Research Evidence

241
Research Sources
55
Avg Quality
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013 PubMed DOI
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014 PubMed DOI
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024 PubMed DOI
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010 PubMed DOI
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010 PubMed DOI
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019 PubMed DOI
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016 PubMed DOI
View all evidence for Niacin →
Compare

Similar Products

View all Niacin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.